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Nowadays, RNA synthesis has become an essential tool not only in the ﬁeld of molecular biology and medicine, but also in
areas like molecular diagnostics and material sciences. Beyond synthetic RNAs for antisense, aptamer, ribozyme, and siRNA
technologies, oligoribonucleotides carrying site-speciﬁc modiﬁcations for structure and function studies are needed. This often
requires labeling of the RNA with a suitable spectroscopic reporter group. Herein, we describe the synthesis of functionalized
monomer building blocks that upon incorporation in RNA allow for selective reaction with a speciﬁc reporter or functional entity.
In particular, we report on the synthesis of 5 -O-dimethoxytrityl-2 -O-tert-butyldimethylsilyl protected 3 -O-phosphoramidites
of nucleosides that carry amino linkers of diﬀerent lengths and ﬂexibility at the heterocyclic base, their incorporation in a variety
of RNAs, and postsynthetic conjugation with ﬂuorescent dyes and nitroxide spin labels. Further, we show the synthesis of a ﬂavine
mononucleotide-N-hydroxy-succinimidyl ester and its conjugation to amino functionalized RNA.
1.Introduction
Over the past two decades, RNA synthesis has become a very
active ﬁeld. Synthetic RNAs are required for a large num-
ber of applications. Antisense oligonucleotides, ribozymes,
aptamers, and siRNAs are required for medicinal diagnostic
and therapy as well as for a wide variety of biochemistry and
molecular biology studies [1, 2]. Furthermore, aptamers and
reporter ribozymes are designed and applied in environmen-
tal diagnostics [3]. A number of other disciplines make use
of synthetic oligoribonucleotides, for example, the ﬁeld of
material science, where novel materials from nanoparticle
oligonucleotide conjugates are generated [4]. In parallel,
RNA synthesis has developed to a degree that allows the
synthesis of RNA oligonucleotides of any desired sequence
from microgram to multigram scale. In addition to 2 -O-
TBDMS chemistry, which may be considered as the standard
procedure for RNA preparation, novel strategies mainly
focussing on diﬀerent 2 -O-protecting groups such as 2 -O-
TOM, 2 -O-ACE or 2 -O-TC are available for laboratory use
applying the speciﬁc monomer building blocks, or have been
commercialized for custom RNA synthesis [5, 6].
Research in our laboratory is devoted to the chemistry
and biochemistry of RNA with a strong focus on RNA
aptamers and ribozymes. Therefore, we synthesize natural
and modiﬁed RNA strands required for the design of
functional RNAs that we want to investigate. Furthermore,
we also prepare RNA molecules carrying site-speciﬁc mod-
iﬁcations such as ﬂuorescent dyes or other reporter groups
to be used for studies into RNA structure. A number of
monomer building blocks for the synthesis of modiﬁed
RNA are commercially available. For example, amino linkers
for 5 - and/or 3 -terminal labeling can be obtained ready
for use in RNA assembly (Figure 1). Furthermore, 5 -O-
DMT-2 -O-TBDMSprotected3 -O-phosphoramiditesof2 -
aminouridine (3) and 4-thiouridine (4)( Figure 1)a r ea v a i l -
able and after incorporation in RNA can be used for the
speciﬁc attachment of desired molecular entities.
However, monomer building blocks of the purine nucle-
osides with functionalities suitable for postsynthetic conju-
gation are completely missing, and also in the pyrimidine
series, the few existing derivatives of uridine do not oﬀer
much variety. Therefore, a currently very active part of our2 Journal of Nucleic Acids
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Figure 1: Structures of the commercially available building blocks used in our RNA functionalization studies.
research is focussed on the synthesis of 5 -O-DMT-2 -O-
TBDMS protected 3 -O-phosphoramidites of nucleosides
that carry functionalized linkers of diﬀerent lengths and
ﬂexibility at the heterocyclic base, in particular at C5 of the
pyrimidines as well as at C8 and C2 of the purines (Figure 2).
Moreover, we currently work at the synthesis of modiﬁed
n u c l e o s i d e sa st h e ya p p e a ri nt R N Aa sw e l la so fi s o t o p e
enrichednucleosidesandtheirincorporationinspeciﬁcRNA
sequences (which will be reported elsewhere).
Herein, we focus on the synthesis of amino-modiﬁed
monomers, their incorporation into RNA, and the postsyn-
thetic labeling with ﬂuorescent dyes. Furthermore, we report
onstrategiesforpreparationofspeciﬁcallyspinlabeledRNAs
for EPR studies, and on the preparation of a ﬂavinmononu-
cleotide (FMN) derivative that is postsynthetically attached
to an amino-modiﬁed hairpin ribozyme derivative. The
modiﬁed RNAs described herein are used in collaboration
with spectroscopists for structural analysis of functional
R N A s ,s u c ha sR N At h e r m o m e t e r s[ 7] and RNA four-way
junctions [8]o rr i b o s w i t c h e s[ 9], or in RNA engineering
projects like the design of an FMN-dependent aptazyme
[10].
2.MaterialsandMethods
2.1. General Information. All reactions were carried out
in dry solvents under argon atmosphere. All solvents and
reagents were purchased from commercial sources and used
as supplied unless otherwise stated. The solvents used in
Pd coupling reactions were freed from oxygen. All products
werevisualizedonTLCplates(aluminiumsheetscoatedwith
silica gel 60F 254, 0.2nm thickness) at 254nm ultraviolet
light. The linker molecules L1, L2, and L3 (Figure 3)w e r e
synthesized according to the literature: the alkinyl linker
L1 was synthesized according to Cruickshank and Stockwell
[11], and alkenyl linkers were synthesized as described by
Dey and Sheppard [12]a n dM c K e e ne ta l .[ 13]. All modiﬁed
phosphoramidites were freshly prepared prior to use in
RNA synthesis. Progress of reaction was monitored by TLC
(hexane/ethyl acetate 1:1 containing 1% NEt3). Phospho-
ramidites were coevaporated several times with dry DCM
and kept under vacuum over P2O5 in a desiccator overnight.
A 0.1M solution of the modiﬁed phosphoramidite in
anhydous acetonitril was freshly prepared right before use in
solid-phase RNA synthesis.
2.2. MALDI-TOF Analysis. For nucleoside derivatives: 1-
2mg sample was dissolved in 100μL methanol or water.
1.5μL of the sample solution and 1.5–3.0μL of the matrix
solution (30–40mg 3-hydroxypicolinic acid (3-HPA) in
500μL MeCN/H2O1 : 1 ,v i g o r o u s l ym i x e df o r3 0 s )w e r e
mixed, and 1-2μLo ft h a tm i x t u r ew a sl o a d e do naM A L D I -
plate, dried, and allowed to crystallize. The sample was
analyzed on a Bruker microﬂex mass spectrometer. The
program was set as reﬂective positive mode with 40–50
shoots/measurement. The laser intensity was adjusted such
that the intensity of the desired signals was about 1000.
For RNA: RNA samples were desalted by gel ﬁltration
on Sephadex G25 ﬁne (GE Healthcare). After desalination,
samples were dissolved in autoclaved micropore water to a
concentration of about 100–500pmol/μL. 1μL of this RNA
solutionwasmixedwith1-2μLofmatrixsolution(30–40mg
3-hydroxypicolinic acid (3-HPA) in 500μL MeCN/H2O
1:1, vigorously mixed for 30s) and treated with cation-
exchange beads (Dowex 50 WX8, NH4
+-form, 100–200
mesh, ServaFeinbiochemica). Therefore, 4–7μL suspension
of the beads in autoclaved micropore water was pipetted in
a 250μL tube, and water was removed, followed by addition
of the sample and matrix solutions. The mixture was left at
rt for 10min then loaded on the MALDI-plate and dried on
air. The sample was measured using the linear negative (or
positive) mode with 40–50 shoots/measurement. In addition
to the main peak [M−1]− (negative mode) or [M+1]+
(positive mode), occasionally the signals corresponding to
[M−2]/2 were observed.
2.3. Synthesis of Amino-Modiﬁed Monomer Building Blocks.
Amino linker-modiﬁed uridine derivatives were synthesized
as described [14]. The detailed synthesis of linker-modiﬁed
adenosine derivatives with focus on the problem of double
bond isomerization will be reported elsewhere (H. Nguyen,
B. Appel, and S. M¨ uller, manuscript in preparation).
2.4. 8-(3-Triﬂuoroacetamidoprop-1-ynyl)guanosine 16. 8-
Bromoguanosine-hydrate 15 (98%) (1448.4mg. 4.0mmol)
was dissolved in dry DMF (32mL). Traces of dissolved
oxygen in the solution were removed by iterative cycles of
reduced pressure and passing in argon (3 times). Then,
Pd(Ph3P)4 (464mg, 0.4mmol, 0.1eq.) was added. The
solution was again kept under vacuum and then saturated
with argon. DIPEA (816μL, 4.8mmol, 1.2eq., freshlyJournal of Nucleic Acids 3
HN
O
O N
N
N N
N
HN
N
N
O
H2N N
N
H
O
HN
O
O N
R
R
N
H
O
HN
O
O N
N
H
O
H
N
O
R
N
N N
N
R
H
N
H
N
R
R
H
N N
N N
N
H
N
5 NH
N
N N
N
R
H
N
N
N N
N
R
H
N
N
H
5
O
R
O
OTBDMS O
DMTO
P
CEO
R = 
5 6 7
8 10
11 12 13
14
O
CF3
CF3
CF3
CF3
CF3
CF3
CF3
CF3
CF3 CF3
O
O
O
O
N
N N
N
R
H
N
9
O
F3C
O
5
N(iPr)2
NHiBu NHiBu NHiBu
NHiBu NHiBu NHiBu
Figure 2: Amino-modiﬁed monomer building blocks used for RNA synthesis and functionalization.
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Figure 3: Amino linkers used for preparation of amino-modiﬁed nucleosides.
distilled over CaH2) was added via a syringe, followed by
the addition of N-propynyltriﬂuoroacetamide L3 (1208mg,
8.0mmol, 2.0eq.) and CuI (152mg, 0.8mmol, 0.2eq.).
The mixture was stirred at 40◦C for 20 hours. The solvent
was then removed to give a brown viscous oil which was
dissolved in DCM/MeOH 1:1 (v/v) and ﬁltered to remove
the precipitate. The solid residue was puriﬁed by silica gel
column chromatography (DCM/MeOH 90:10 to 84:16
(v/v)) to give a pale yellow solid. Yield: 2765.4mg (6.4mmol,
80%). Rf (SiO2; DCM/MeOH 60:40 (v/v)): 0.80. 1HN M R
(300MHz, DMSO-d6): δ (ppm) = 3.50 (1H, m, H-5 ), 3.64
(1H, m, H-5  ), 3.84 (1H, m, H-4 ), 4.12 (1H, m, H-3 ),
4.36 (2H, d, J 5.4, CH2), 4.88 (2H, m, H-2  and OH), 5.04
(1H, d, J 4.8, OH), 5.40 (1H, d, J 6.0, OH), 5.76 (1H, d, J
6.3, H-1 ), 6.57 (2H, br s, NH2), 10.20 (1H, t, J 5.4, NH),
10.90 (1H, br s, NH). 13C NMR (300 MHz, DMSO-d6):
δ (ppm) = 29.40, 62.06, 70.47, 70.85, 72.75, 85.77, 88.38,
89.12, (110.03, 113.84, 117.65 and 121.47, q, J 288.02, CF3),
117.24, 129.04, 150.90, 154.12, (155.54, 156.03, 156.51
and 157.00, q, J 36.76, (C=O)CF3), 156.24. MALDI-TOF:
C15H15F3N6O6, calculated 432.10, found 432.82 [M+H]+.
2.5. N-2-Isobutyryl-8-(3-triﬂuoroacetamidoprop-1-ynyl)gua-
nosine 17. 8-(3-Triﬂuoroacetamido-prop-1-ynyl)guanosine
16 (216.5mg, 0.50mmol) was coevaporated with anhydrous
pyridine (3 × 4mL), and then dissolved in anhydrous
pyridine (2mL). The resulting solution was protected from
moisture(dryingtube),purgedwithargonandplacedonice.
Totheicecoldsolution,TMS-Cl(0.55mL,4.1mmol,8.2eq.)
was added dropwise via a syringe. The ice bath was then
removed and the mixture was stirred for 2 hours. The solu-
t i o nw a sc o o l e do ni c ea n di s o b u t y r i ca n h y d r i d e( 0 . 1 3m L ,
1.1mmol, 2.2eq.) was added dropwise via a syringe and the4 Journal of Nucleic Acids
ice bath was removed. After stirring for another 2 hours at
room temperature, the reaction was placed again on ice and
ice cold water (20mL) was slowly added, followed after 15
minutes by concentrated ammonia solution (1.5mL) to get a
ﬁnal 2.5M concentration of ammonia. The mixture was kept
on ice for 30 minutes, and then evaporated to dryness. The
residue was coevaporated with toluene (3 × 5mL)toremove
t r a c e so fw a t e r ,r e s u s p e n d e di nM e O Ha n dﬁ l t e r e dt or e m o v e
the precipitate. The ﬁltrate was then concentrated, dissolved
in a small amount of MeOH, absorbed on silica gel and puri-
ﬁedbycolumnchromatography(DCM/MeOH95:5to91:9
(v/v))togiveN-2-isobutyryl-8-(3triﬂuoroacetamidoprop-1-
ynyl)guanosineasayellowsolid.Yield:183.3mg(0.37mmol;
73%). Rf (SiO2; DCM/MeOH 80:20 (v/v)): 0.63, 1HN M R
(300MHz, DMSO-d6): δ (ppm)= 1.13 (6H, d, J 6.9,
CH(CH3)2), 2.79 (1H, sept, J 6.9, CH(CH3)2), 3.53 (1H, m,
H-5 ),3.68(1H,m,H-5  ),3.84(1H,m,H-4 ),4.17(1H,br
s, H-3 ), 4.40 (2H, s, CH2), 4.81 (1H, br s, H-2 ), 4.91 (1H,
br s, OH), 5.09 (1H, br s, OH), 5.50 (1H, br s, OH), 5.86
(1H, d, J 6.0, H-1 ), 10.21 (1 H, br s, NH), 11.62 (1 H, br s,
NH), 12.16 (1 H, br s, NH). MALDI-TOF: C19H21F3N6O7,
calculated 502.14, found 502.84 [M+H]+.
2.6. 5 -O-(4,4 -Dimethoxytrityl)-N-6-isobutyryl-8-(3-triﬂu-
oroacetamidoprop1ynyl)guanosine 18. N-2-Isobutyryl-8-
(3-triﬂuoroacetamidoprop-1-ynyl)guanosine 17(1174.4mg,
2.4mmol) was coevaporated with anhydrous pyridine (3 ×
3mL) and dissolved in anhydrous pyridine (10.0mL).
DMT-Cl (1219.8mg, 3.6mmol, 1.5eq.) was dissolved in
anhydrous pyridine (3.0mL) and added dropwise to the
ice cold solution of the nucleoside over 2.5 hours. After
6 hours at ice cold temperature, TLC analysis (DCM/
MeOH 95:5(v/v)) showed that the starting material was
completely consumed. Methanol (1.0mL) was added to
quench the unreacted DMT-Cl, and after 10 minutes,
the solution was concentrated to dryness in vacuo.T h e
residue was dissolved in DCM (100mL), washed with a
5% aqueous solution of NaHCO3 (2 × 20mL) and water
(2 × 20mL). The organic layer was dried over Na2SO4 and
concentrated to give a yellow gum which was puriﬁed by
c o l u m nc h r o m a t o g r a p h y( D C M / M e O H9 7:3t o9 5:5( v / v )
containing 1% triethylamine) to give a pale yellow foam.
Yield: 1671.6mg (2.08mmol, 87%). Rf (DCM/MeOH 90:10
(v/v)): 0.44.1H NMR (300MHz, DMSO-d6): δ (ppm) = 1.11
(6H, 2 × d, J 6.9 and 6.6, CH(CH3)2), 2.72 (1H, sept, J 6.9,
CH(CH3)2), 3.11 and 3.45 (2 H, m, H-5  and H-5  ), 3.69
and 3.71 (6H, 2 × s, 2 × OCH3), 4.04 (1H, m, H-4 ), 4.31
(3H, br s, H-3  and CH2), 4.91 (1H, m, H-2 ), 5.04 (1H,
br s, OH), 5.61 (1H, br s, OH), 5.94 (1H, d, J 4.5, H-1 ),
6.73 (4H, 2 × d, J 8.7 and 9.0, aromatic), 7.23 (9H, m,
aromatic), 10.85 (3H, br s, 3 × NH). 13C NMR (300MHz,
DMSO-d6): δ (ppm) = 18.71, 18.94, 29.33, 34.80, 54.86,
54.91, 64.72, 70.49, 71.36, 72.06, 84.21, 85.21, 89.91, 90.49,
(110.02, 113.82, 117.65 and 121.47, q, J 288.5, CF3), 112.73,
112.82, 120.83, 126.45, 127.47, 127.78, 129.64, 129.80,
131.52, 135.58, 144.87, 148.24, 154.33, (155.55, 156.05,
156.53 and 157.03, q, J 37.0, (C=O)CF3), 157.88, 157.95,
180.09. MALDI-TOF: C40H39F3N6O9, calculated 804.27,
found 805.24 [M+H]+.
2.7. 5 -O-(4,4 -Dimethoxytrityl)-2 -(tert-butyldimethylsilyl)-
N-2-isobutyryl-8-(3-triﬂuoroacetamidoprop-1-ynyl)guanosine
19. 5 -O-(4,4 -Dimethoxytrityl)-N-2-isobutyryl-8-(3-tri-
ﬂuoroacetamidoprop-1-ynyl)guanosine 18 (1623mg,
2.02mmol) was coevaporated with anhydrous pyridine
(2mL × 2), dry DCM (2 × 5mL), kept under vacuum
overnight, and then dissolved in anhydrous THF (20mL).
Anhydrous pyridine (606μL, 7.47mmol, 3.7eq.) and
AgNO3 (505mg, 3.0mmol, 1.5eq.) were added. The re-
action mixture was stirred for 15 minutes to give a white
emulsion, and TBDMS-Cl (528mg, 3.43mmol, 1.7eq.)
was added. The reaction was protected from moisture and
stirred at room temperature until TLC (SiO2,h e x a n e / e t h y l
acetate 1:1 (v/v)) showed no starting material left (8.5
hours). The reaction mixture was diluted with ethyl acetate
(50mL), ﬁltered to remove the precipitate and washed
with a saturated solution of NaHCO3 (2 × 20mL). The
organic layer was dried over Na2SO4 and concentrated
under reduced pressure to give a white gum which was then
puriﬁed by silica gel column chromatography (hexane/ethyl
acetate 85:15 to 40:60 (v/v)) to give a pale yellow foam.
Yield: 482.3mg (0.53mmol, 26%). Rf (SiO2;h e x a n e / e t h y l
acetate 1:1 (v/v) containing 4% MeOH): 0.41. 1HN M R
(300MHz, DMSO-d6): δ (ppm) = −0.14 and −0.02 (6H,
2 × s, Si(CH3)2), 0.76 (9H, s, SiC(CH3)3), 1.09 (6H, 2 ×
d, J 6.6 and 6.9, CH(CH3)2), 2.70 (1H, sept, J 6.6 and 6.9,
CH(CH3)2), 3.19 (1H, m, H-5 ), 3.51 (1H, m, H-5  ), 3.67
and 3.69 (6H, 2 × s, 2 × OCH3), 4.09 (1H, m, H-4 ), 4.20
(1H, br m, H-3 ), 4.38 (2H, br d, J 5.1, CH2), 4.79 (1H,
m, H-2 ), 5.95 (1H, d, J 4.8, H-1 ), 6.75 (4H, 2 × d, J 8.7,
aromatic), 7.27 (9H, m, aromatic), 10.16 (1H, t, J 5.1 and
5.4, NH), 11.38 (1H, br s, NH), 12.14 (1H, br s, NH).
13C NMR (300MHz, DMSO-d6): δ (ppm) = −5.40, −4.91,
17.81, 18.63, 18.88, 25.47, 29.24, 34.77, 54.89, 54.93, 64.49,
70.16, 71.95, 73.74, 84.26, 85.30, 90.66, (109.97, 113.79,
117.61 and 121.43, q, J 288.40, CF3), 112.82, 112.87, 126.51,
127.55, 127.76, 129.70, 129.78, 135.50, 135.58, 144.86,
148.52, 154.10, (155.54, 156.03, 156.52 and 157.01, q, J
37.0, (C=O)CF3), 157.93, 157.98, 180.07. MALDI-TOF:
C46H53F3N6O9Si, calculated 918.36, found 919.19 [M+H]+.
2.8. 5 -O-(4,4 -Dimethoxytrityl)-2 -(tert-butyldimethylsilyl)-
N-2-isobutyryl-8-(3-triﬂuoroacetamidoprop-1-ynyl)guano-
sinephosphoramidite 14. 5 -O-(4,4 -Dimethoxytrityl)-2 -
(tert-butyldimethylsilyl)-N-2-isobutyryl-8-(3-triﬂuoroacet-
amidoprop-1-ynyl)guanosine 19 (67.96mg, 0.11mmol)
was coevaporated with anhydrous pyridine (2 × 5mL),
dry DCM (2 × 5mL), kept under vacuum overnight, and
then dissolved in anhydrous DCM (2mL). To the resulting
solution, DIPEA (75μL, 0.44mmol, 4eq.) was added,
followed by 2-cyanoethyl-N,N-diisopropylchlorophospho-
ramidite (37μL, 0.16mmol, 1.5eq). The solution was
stirred at room temperature. The reaction was followed
by TLC (EtOAc:hexane 1:1 containing 1% TEA). After
2.5 hours, the reaction was stopped and washed with a
saturated solution of NaHCO3 (10mL). The organic layer
was dried over Na2SO4 and ﬁltered, and the solvent was
removed under reduced pressure. The residue was puriﬁed
by silica gel column chromatography. The column wasJournal of Nucleic Acids 5
packed with DCM/TEA (98:2), the residue was dissolved
in 1-2mL DCM/TEA (98:2), and the column was loaded.
After 30mL of DCM/TEA (98:2), the solvent was changed
to DCM/TEA/MeCN (49:1:50, 50mL). The fractions
containing the desired product were collected, and the
solvent was removed under reduced pressure. The product
was lyophilized overnight. 31P-NMR (300MHz, DMSO-d6),
two diastereomers: δ (ppm) = 148.98, 149.71.
2.9. RNA Synthesis. Oligoribonucleotides were synthesized
by the phosphoramidite method on a Pharmacia Gene
Assembler Plus, at 1μmol scale as described elsewhere [15].
Standard PAC-phosphoramidites as well as CPG supports
were obtained from ChemGenes or Link Technologies. BMT
(emp Biotech) was used as activator [16]. The modiﬁed
nucleoside phosphoramidites were coevaporated three times
with dry dichloromethane, kept under vacuum for 2 hours
to remove traces of solvents, stored in vacuum over P2O5
overnight, and used in oligo synthesis as 0.1–0.15M solution
in acetonitrile. The solutions of phosphoramidites, BMT,
and MeCN were kept over molecular sieve 0.3nm. The
coupling time for all natural and modiﬁed building blocks
was 5min. All syntheses were carried out “trityl-oﬀ”. The
obtainedRNAwascleavedfromthesupportanddeprotected
using NH3 (30%) and ethanolic methylamine in a 1:1
mixture and TEAx3HF as described [17] and puriﬁed by gel
electrophoresis using 10% denaturing polyacrylamide gels.
Elutionwascarriedoutusing0.5MLiOAcfollowedbyEtOH
precipitation. Oligonucleotides were analyzed by PAGE and
MALDI MS.
2.10. Postsynthetic Labeling of Oligoribonucleotides with
Alexa488, Cy5 and ATTO647N. 5 to 10nmol amino-
modiﬁed RNA were dissolved in 15–25μL 0.1M Borax
buﬀer, at pH 9.4 for Alexa488 coupling reactions, and at
pH 8.7 for Cy5 and ATTO647N coupling reactions. The
mixture was added to a solution of 100μgd y ei n5 μL
DMF (the solution of the dye in DMF was freshly prepared
just before use). The coupling reaction was carried out at
room temperature overnight in the dark. Excess of dye was
removed via gel ﬁltration (Sephadex G25 ﬁne, GE Health-
care). The Alexa488 and Cy5 labeled RNAs were puriﬁed by
denaturing PAGE. The sample was denatured at 90◦Cf o r3
minutes, immediately subjected onto a 15% polyacrylamide
gel (200 × 150 × 1.5mm), and electrophoresis was run at
400V for 5.5 hours in the dark. The band corresponding
to the labeled RNA was cleaved out; the RNA was eluted
with 0.5M lithium acetate and precipitated from ethanol
at −20◦C (yield 15–37% for Alexa488, 26–54% for Cy5).
The ATTO647N labeled RNA was puriﬁed by reverse-phase
HPLC. The RNA was solved in 1mL water and ﬁltered
through a 0.45μL ﬁlter before subjecting onto the column.
Column EC 250/4 Nucleodur 100-5 C18 ec (Macherey-
Nagel), ﬂow rate 0.5mL/min, Buﬀer A 0.1M TEAAc (pH
7), 5% MeCN, Buﬀer B 0.1M TEAAc (pH 7), 70% MeCN,
Gradient 0% B for 5min, 10–55% B in 76min, 55–100% B
in 19 minutes(yield 40–50%).
2.11. Hybridization of Single-Stranded RNAs for Structural
Studies on RNA Thermometer
Condition A. For the hybridization of unlabeled single-
stranded oligonucleotides, D1L3 (300pmol) and A1L3
(300pmol) were dissolved in 50mM Tris buﬀer, pH 7.4 in
the presence of 10mM MgCl2 in a total volume of 100μL.
The solution was then well mixed, incubated at 78◦Cf o r
3 minutes, centrifuged to collect the vapor on the cap of
the eppendorf tube, wrapped in aluminium ﬁlm, and slowly
cooled down to room temperature. The hybrid was analyzed
by 15% native polyacrylamide gel.
Condition B. Alexa Fluor 488-labeled D1L3 (25pmol) and
Cy5-labeled A1L3 (25pmol), were dissolved in 20mM
KH2PO4-K2HPO4 buﬀer, pH 6.5 in the presence of 10mM
MgCl2 and 100mM KCl in a total volume of 50μL. The
components were then mixed, centrifuged and incubated at
78◦C for 3 minutes. The mixture was slowly cooled down to
roomtemperatureinaluminiumﬁlm.Thehybridization was
checked by 15% native polyacrylamide gel.
2.12. 5 -O-(4,4 -Dimethoxytrityl)riboﬂavin 21. To a suspen-
sion of riboﬂavin 20 (1.5g, 4mmol) in dry pyridine TEA
(2mL, 14.4mmol), DMAP (24mg, 0.2mmol), and 4,4 -
dimethoxytritylchloride (1.7g, 5.2mmol) were added under
argon. After 4 hours of stirring at room temperature in
the dark, the reaction was quenched with dry methanol
(5mL). The solvent was evaporated under reduced pressure.
The residue was dissolved in DCM (100mL) and ﬁltered.
The clear yellow ﬁltrate was dried with Na2SO4 and the
solvent was removed. Puriﬁcation of the crude product by
column chromatography with DCM/MeOH (98:2) gave
the tritylated product 21 as an orange solid. Yield: 1.4 g
(2.1mmol, 53%). 1H NMR (300MHz, DMSO-d6): δ (ppm)
= 2.39 (s, 3H, CH3), 2.41 (s, 3H, CH3), 3.20–3.17 (m, 2H),
3.72 and 3.73 (2 × s, 2 × 3H ,2× OCH3), 3.92 (br s, 1H),
4.23 (br s, 1H), 4.62 (m 1H), 4.98 (m, 1H), 6.85 (m, 4H,
DMT), 7.46–7.16 (m, 9H, DMT), 7.83 (s, 1H), 7.90 (s, 1H),
11.34 (s, 1H, NH). ESI-MS: C38H38N4O8, calculated 678.27,
found 677.26 [M−H]−.
2.13. 2 ,3 ,4 -Tri-O-acetyl-5 -O-(4,4 -dimethoxytrityl)ribo-
ﬂavin 22. 5 -O-(4, 4 -Dimethoxytrityl)-riboﬂavin 21 (1.4g,
2.06mmol) in dry pyridine (200mL) was cooled in an ice
bath under argon atmosphere. After dropwise addition of
acetic anhydride (7.6mL, 80mmol), the solution was stirred
in the dark at room temperature overnight. Then, methanol
(5mL) was added, and the solvent was evaporated. Column
chromatography with DCM/MeOH (98:2) gave the title
compound 22asorangefoam.Yield:1.5g(1.86mmol,90%).
1H NMR (300MHz, DMSO-d6): δ (ppm) = 1.49 (s, 3H,
acetyl-CH3), 2.02 (s, 3H, acetyl-CH3), 2.27 (s, 3H, acetyl-
CH3), 2.39 (s, 3H, CH3), 2.46 (s, 3H, CH3), 3.12–3.05 (m,
1H), 3.29–3.22 (m, 1H), 3.73 (2 × s, 2 × 3H,2× OCH3),
5.16–4.79 (br m, 2H), 5.24 (m, 1H), 5.54 (m, 2H), 6.88 (m,
4H, DMT), 6.37–7.20 (m, 9H, DMT), 7.64 (s, 1H), 7.89 (s,
1H), 11.40 (s, 1H, NH), ESI-MS: C44H44N4O11, calculated
804.30, found 803.29 [M−H]−.6 Journal of Nucleic Acids
2.14. 2 ,3 ,4 -Tri-O-acetylriboﬂavin 23. 2 ,3 ,4 -Tri-O-
acetyl-5 -O-(4,4 -dimethoxytrityl)riboﬂavin 22 (500mg,
0.6mmol) was dissolved in 20mL nitromethane. To this
solution, anhydrous ZnBr2 (1.25g, 5.6mmol) was added.
After 2 minutes, the reaction was quenched by addition of
ammonium acetate (50mL, 1M in water). DCM (50mL)
were added, the organic layer was separated and washed with
brine (2 × 20 mL), followed by evaporation under reduced
pressure. The crude product was extracted several times with
ice cold diethyl ether to remove residual DMT. In this way,
compound 23 (250mg, 0.5mmol) were obtained as a yellow
solid. The product was used for the next reaction without
further puriﬁcation. MALDI-TOF: C23H26N4O9, calculated
502.17, found 503.23 [M+H]+.
2.15. 3-(Tetraethylene glycol)propionic Acid tert-Butyl Ester
25. Tetraethylene glycol 24 (38.8g, 200mmol) was dissolved
in dry THF (80mL). Under argon atmosphere, sodium
(0.2g, 8.7mmol) was added. After all of the sodium had
dissolved,tert-butylacrylate(7.7g,60mmol)wereaddedand
the mixture was stirred at room temperature for 23 hours.
The slightly yellow solution was neutralized with 1M HCl
and the solvents were evaporated under reduced pressure.
The residue was redissolved in brine (80mL) and extracted
with ethyl acetate (3 × 50mL). The combined organic layers
were washed with water and dried with sodium sulfate.
After evaporation of the solvents, the oil was subjected to
column chromatography on silica gel (DCM/MeOH 98:2)
to give 25 as colorless oil. Yield: 6.65g (20.6mmol, 34%).
1H NMR (300MHz, CDCl3): δ (ppm) = 1.45 (s, 9H, tert-
butyl), 2.50 (t, 2H, CH2-COO-tert-Bu), 3.74–3.60 (m, 18H,
OCH2CH2O). MALDI-TOF: C15H30O7, calculated 322.20,
found 345.16 [M+Na]+.
2.16. 3-(Tetraethylene glycol)propionic Acid tert-Butyl Ester
Phosphoramidite 26. 3-(Tetraethylene glycol)propionic acid
tert-butyl ester 25 (1g, 3.1mmol) was coevaporated three
times with dichloromethane and then dissolved in 25mL
DCM under argon. To this solution, freshly distilled DIPEA
(2.5mL) and 2-cyanoethyl-N,N-diisopropropylchlorophos-
phoramidite (0.85ml, 3.6mmol) were added. After 1.5
hours, the reaction was stopped by addition of 1mL
methanol.Themixturewasdilutedwithethylacetate(20mL)
and TEA (1.5mL) and washed with a saturated solution of
NaHCO3 (25mL) and brine (25mL). The organic layer was
dried with Na2SO4, and the solvents were removed under
reduced pressure. The crude product was coevaporated three
times with dry DCM and stored overnight in an evacuated
desiccator with calcium chloride. According to TLC analysis,
the phosphoramidite was suﬃciently pure to be used for the
next reaction without further puriﬁcation. 31P NMR (300
MHz, CDCl3), two diastereomers: δ (ppm) = 148.45, 149.37.
2.17. 5 -O-(3-(Tetraethylene glycol)propionic Acid tert-Butyl
Ester-β-cyanoethylphosphoryl)-2 ,3 ,4 -tri-O-Acetylriboﬂavin
27. All starting materials were coevaporated separately
with dry DCM. The riboﬂavine derivative 23 (100mg,
0.2mmol) was dissolved in dry MeCN (15mL). To this
solution, phosphoramidite 26 (136mg, 0.26mmol) in 2mL
dry MeCN and BMT (192mg, 1mmol) in 3mL MeCN
were added. The reaction mixture was stirred for 1 hour
at room temperature. A solution of 0.2M iodine in a
mixture of THF/pyridine/H2O(2:1:1)wasadded.Afterten
minutes, sodium bisulﬁte (5% in water) was added until the
brown color had vanished. The mixture was diluted with
DCM (40mL). The organic layer was washed with sodium
bicarbonate and brine and ﬁnally dried over sodium sulfate.
The solvents were evaporated under reduced pressure. The
residue was puriﬁed by reversed phase HPLC. Column
VP125 Nucleosil 120-10 C18 ec (Macherey-Nagel), ﬂow
rate 0.5mL/min, Eluent A 10% MeOH, Eluent B 70%
MeOH, Gradient 0–70% B in 5CV, 70–100% B in 3CV,
100% B 3CV. Yield: 59.5mg (63nmol, 32%). 1HN M R
(300MHz, CDCl3), two diastereomers: δ (ppm) = 1.44 (s,
9H,tert-butyl), 1.79 (s, 3H), 2.21 (2 × s, 3H), 2.35 and 2.33
(2 × s, 3H), 2.44 (s, 3H), 2.50 (t, 2H, CH2-COO-tert-Bu),
2.57 (s, 3H), 2.81 (m, 2H, CH2-CN), 3.74–3.60 (m, 18H,
OCH2CH2O), 4.40–4.21 (m, 6H, P-O-CH2), 5.33–4.89
(br, 2H), 5.41 (m, 1H), 5.50 (m, 1H), 5.65 (m, 1H), 7.60
and 7.59 (2 × s, 1H), 8.02 (s, 1H), 8.80 and 8.76 (2 × s,
1H, NH). MALDI-TOF: C41H58N5O18P, calculated 939.35,
found 962.62 [M+Na]+.
2.18. 5 -O-(3-(Tetraethylene glycol)propionic Acid-β-cya-
noethylphosphoryl)-2 ,3  ,4  -tri-O-Acetylriboﬂavin 28. The
fully protected coupling compound 27 (25mg, 26.6nmol)
was treated with 1mL DCM/TFA (1:1) for 1 hour at room
temperature. Subsequently, the solvents were evaporated
under reduced pressure, and the residue was puriﬁed by
reversed phase HPLC to give the free acid as an orange solid.
Column VP125 Nucleosil 120-10 C18 ec (Macherey-Nagel),
ﬂow rate 0.5mL/min, Eluent A 10% MeOH, Eluent B 70%
MeOH, Gradient 0–70% B in 5CV, 70–100% B in 3CV,
100% B 3CV. Yield 18.8mg (21.3nmol, 80%). 1HN M R
(300MHz, DMSO-d6), two diastereomers: δ (ppm) = 1.61
(s, 3H), 2.20 (s, 3H), 2.25 (s, 3H), 2.41 (s, 3H), 2.43 (t,
2H, CH 2-COOH), 2.51 (s, 3H), 2.93 (m, 2H, CH2-CN),
3.63–3.48 (m, 18H, OCH2CH2O), 4.41–4.10 (m, 6H, P-
O-CH2), 4.83 (d, 1H), 5.18–5.00 (br, 1H), 5.32 (m, 1H),
5.48 (m, 2H), 7.73 (s, 1H), 7.90 (s, 1H), 11.40 (s, 1H,
NH).MALDI-TOF:C37H50N5O18P,calculated883.29,found
906.43 [M+Na]+.
2.19. 5 -O-(3-(Tetraethylene glycol)propionic Acid Phospho-
ryl)riboﬂavin 29. In 4mL of a 30% ammonia solution in
methanol, the riboﬂavin derivative 28 (15mg, 17nmol) was
dissolved and stirred at room temperature. After 30min,
MALDI analysis showed complete conversion to product.
The solvents were evaporated, and the solid was taken up in
1mL deionized water and subjected onto a short DOWEX
column (H+ form, 4 × 1.5cm). The product was eluted with
water and dried in vacuo. Yield: 11mg (15.6nmol, 92%).
1H NMR: (600MHz, DMSO-d6): δ (ppm) = 2.40 (s, 3H),
2.43 (t, 2H, CH2-COOH), 2.49 (s, 3H), 3.61–3.47 (m, 16H,
OCH2CH2O ) ,3 . 6 4( m ,1H ) ,3 . 8 6( m ,1H ) ,3 . 9 0( m ,1H ) ,
4.00 (m, 2H), 4.11 (m, 1H), 4.24 (m, 1H), 4.65 (d, 1H),Journal of Nucleic Acids 7
4.89(m,1H),7.90(s,2H),11.35(s,1H,NH).MALDI-TOF:
C28H41N4O15P, calculated 704.23, found 705.32 [M+H]+.
2.20. Introduction of Spin Labels to RNA Containing 4-
Thiouridine. The modiﬁed nucleotide 4-thiouridine was
incorporated at preselected positions of RNAs, to be
used for postsynthetic spin labeling with 1-oxyl- 2,2,5,5-
tetramethylpyrroline-3-methyl)methane-thiosulfonate or
N-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)iodoacetam-
ide. RNA samples were incubated for 2 hours at room
temperature with a 200-fold excess of dithiothreitol (DTT)
in 50μL of 100mM sodium phosphate puﬀer (pH 8.0).
The reducing agent was removed by demineralization using
centrifugal ﬁlters, followed by lyophilization of the RNA.
Spin labeling was carried out overnight by incubation of a
100μM solution of the respective RNA in 90mM sodium
phosphate buﬀer (90% v/v) (pH 8.0) and DMF (10%
v/v) with a 10-fold excess of 1-oxyl-2,2,5,5-tetrameth-
ylpyrroline-3-methyl)methanethiosulfonate or N-(1-oxyl-
2,2,5,5-tetramethyl-3-pyrrolidinyl)iodoacetamide, respec-
tively. Unbound nitroxide reagent was removed by deminer-
alization and lyophilization as described above. The spin
label eﬃciency ranged from 10% to 100%.
2.21. Introduction of Spin Labels to RNA Containing 2 -Ami-
nouridine. RNAs were synthesized with 2 -aminouridine at
predeﬁned positions and subsequently spin labeled.
2.21.1. Reaction with (1-Oxyl-2,2,5,5-tetramethylpyrrolin-
3-carboxylat)-N-Hydroxysuccinimidyl Ester. As o l u t i o no f
the RNA in 80mM borax buﬀer (pH 8.5) (90% v/v), DMF
(10% v/v) containing 10mM NaCl was incubated for 5
hours at 37◦C with a 500-fold excess of (1-oxyl-2,2,5,5-
tetramethylpyrrolin-3-carboxylat)-N-hydroxysuccinimidyl
ester. Side products and unreacted reagents were extracted
with 300μL chloroform at room temperature followed by
precipitation of the labeled RNA from ethanol. The pellet
was resolved in water, the solution was demineralized using
centrifugal ﬁlters, and ﬁnally, the sample was lyophilized.
Yields were between 70% and 80%.
2.21.2. Reaction with 4-Isocyanato-2,6-tetramethylpiperidyl-
N-oxid. As o l u t i o no ft h eR N Ai n5 0m Mb o r a xb u ﬀer (pH
8.5) (50% v/v), DMF (20% v/v) and formamide (30% v/v)
was cooled to −8◦C and incubated for 2 hours with a
15-fold excess of 4-isocyanato-2,6-tetramethylpiperidyl-N-
oxid. Side products and unreacted reagent were extracted
with 300μL chloroform at room temperature followed by
precipitation of the labeled RNA from ethanol. The pellet
was resolved in water, the solution was demineralized using
centrifugal ﬁlters, and ﬁnally, the sample was lyophilized.
Yields were between 75% and 100%.
3. Results andDiscussion
3.1. Synthesis of Natural and Modiﬁed RNA with Com-
mercially Available Building Blocks. The coupling reaction
of RNA phosphoramidites is less facile than that of DNA
phosphoramidite building blocks; hence, the coupling yields
normally are slightly poorer. Thus, chemical synthesis of
RNA is limited by the length of the oligomers. Up to
now, we, therefore, preferred to synthesize nonmodiﬁed
RNA molecules which are longer than 70 bases by in vitro
transcriptiontechniquesasdescribed[17].Shorternonmod-
iﬁed and modiﬁed RNAs in our laboratory are prepared
by solid phase synthesis. Our procedure is based on 2 -
O-tert-butyldimethylsilyl (TBDMS) nucleoside protection
and involves sequential couplings of β-cyanoethyl-(N,N -
diisopropyl)phosphoramidites of 5 -O-dimethoxytrityl-2 -
O-TBDMS nucleosides essentially by the method as
described [17]. For assembly of the oligoribonucleotides, we
predominantly use CPG or polystyrene beads to which the
ﬁrstribonucleosidederivativeisattachedviaits3 -OHgroup
asasuccinatelinkage.Thestandardsynthesisisonthemicro-
mole scale, and for coupling of phosphoramidites, we use 5-
benzylmercaptotetrazole activation [16] and coupling times
of 5min. Under these conditions, the yields in couplings are
usually in the 99% range. We have synthesized a variety of
amino- and 4-thiouridine-modiﬁed RNAs (Tables 1, 2,a n d
3)thatwerepostsyntheticallyfunctionalizedwithﬂuorescent
dyes, spin labels, or ﬂavine mononucleotide as described
below.
The 5 -a n d3  -amino modiﬁers, as well as 4-thiouridine
were introduced during RNA solid phase synthesis using
commercially available building blocks (Figure 1). While for
the 5 -amino modiﬁer, the standard coupling conditions
were used, 4-thiouridine was introduced by two consecutive
couplings of 5 minutes each using fresh amidite solution.
After chain assembly was completed, cleavage from the
solid support and removal of base-protecting groups were
accomplished by treatment with aqueous NH3 (30%) and
ethanolic methylamine in a 1:1 mixture for 2h at room
temperature. We found this protocol advantageous over
the usage of NH3/MeOH, as we had applied previously
[18]. Finally, 2 -O-TBDMS groups were removed by ﬂuoride
ion treatment. While 1M tetrabutylammonium ﬂuoride
was conventionally used for this purpose, we prefer the
use of triethylamine trihydroﬂuoride ﬁrst suggested by
Gasparutto et al. [19]. In combination with polar aprotic
solvents and at elevated temperatures, this reagent oﬀers
advantages in speed and reliability [20]. Therefore, we use
triethylamine trihydroﬂuoride/DMF (3:1) at 55◦Cf o r1 . 5
hours for eﬃcient removal of the 2 -O-TBDMS groups.
Following deprotection, oligonucleotides were desalted by
precipitation with n-butanol and puriﬁed by electrophoresis
ondenaturingpolyacrylamidegelsorbyHPLC.Theyieldsof
oligonucleotides shown in Tables 1–3 were in the range of 1
to 400nmol after puriﬁcation.
3.2. Synthesis of Amino-Modiﬁed RNA Building Blocks
and Incorporation in RNA. Within a collaborative research
project, the three-dimensional architecture of structured
RNAs,forexample,RNAthermometers[7]orRN Afour -wa y
junctions [8],is investigated byquantitative ﬂuorescenceres-
onance energy transfer (FRET) measurements. For absolute
distance measurements by FRET, the microenvironment of
the probe attached to thesample is very important. However,8 Journal of Nucleic Acids
Table 1: Sequences of synthesized linker-modiﬁed RNA oligonucleotides. The bold letters (U/A) mark the position of the modiﬁcation (see
Figure 2).
Name Length Sequence Mod. Dye
A1L1 25nts UGG CAA GCU CGC AGU CGG CAC CGC C 5 Cy5
A1L2 25nts UGG CAA GCU CGC AGU CGG CAC CGC C 6 Cy5, ATTO
647N
A1L3 25nts UGG CAA GCU CGC AGU CGG CAC CGC C 7 Cy5
A2L1 25nts UGG CAA GCU CGC AGU CGG CAC CGC C 5 Cy5
A2L2 25nts UGG CAA GCU CGC AGU CGG CAC CGC C 6 Cy5, ATTO
647N
A2L3 25nts UGG CAA GCU CGC AGU CGG CAC CGC C 7 Cy5
D1L1 25nts GGC GGU GCC GAC UGC GAG CUU GCC A 5 Alexa 488
D1L2 25nts GGC GGU GCC GAC UGC GAG CUU GCC A 6 Alexa 488
D1L3 25nts GGC GGU GCC GAC UGC GAG CUU GCC A 7 Alexa 488
L2-TEST 8nts GGA AUUC C 6 —
2-L3-A 8nts GGA AUU CC 7 ATTO 647N
8-L1-A 8nts UUA GUA CU 8 —
2-L3-A 8nts GGA AAU CC 10 ATTO 647N
RNA-25 32nts CCC CAC GUC AAG GCG UGG UGG CCG AAG GUC GG 6 Cy5
RNA-26 32nts CCG ACC UUC GGC CAC CUG ACA GUC CUG UGG GG 6 Alexa 488
4U-Ther. 60nts GGC GGU GCC GAC UGC GAG CUU GCC AUG UUG AAC UUU
UGA AUA GUG AUU CAG GAG GUU AAU 6 Alexa 488
4U-Ther. 60nts GGC GGU GCC GAC UGC GAG CUU GCC AUG UUG AAC UUU
UGA AUA GUG AUU CAG GAG GUU AAU 6 Alexa 488
4U-Ther. 60nts GGC GGU GCC GAC UGC GAG CUU GCC AUG UUG AAC UUU
UGA AUA GUG AUU CAG GAG GUU AAU 6 Alexa 488
4U-Ther. 60nts GGC GGU GCC GAC UGC GAG CUU GCC AUG UUG AAC UUU
UGA AUA GUG AUU CAG GAG GUU AAU 6 Alexa 488
4U-Ther. 60nts GGC GGU GCC GAC UGC GAG CUU GCC AUG UUG AAC UUU
UGA AUA GUG AUU CAG GAG GUU AAU 6 Alexa 488
the commercial availability of building blocks for internal
labeling of RNA is rare. Therefore, often molecules with a
deoxy sugar moiety at the position of the internal label are
applied for structural studies. In order to provide a set of
nucleotides that upon incorporation in RNA can be used for
RNAfunctionalizationatadesiredinternalsite,westartedan
eﬀort to synthesize various ribonucleoside phosphoramidite
building blocks with amino linkers of diﬀerent lengths and
ﬂexibility attached to the heterocyclic base. We choose one
short (L1) and one long (L2) rather ﬂexible linker (Figure 3)
coupled to the nucleobases by Heck chemistry [12, 13]a n d
a short alkynyl linker (L3) (Figure 3) that was introduced by
Sonogashira coupling [11].
In a ﬁrst row of experiments, we have attached the three
diﬀerent linkers at C5 of uridine by palladium catalyzed
cross-coupling reactions as described [14] (see 5, 6,a n d7
in Figure 2).
Furthermore, adenosine derivatives with alkenyl linkers
L1andL2atC8orC2werepreparedunderanalogouscondi-
tionsasusedforuridinederivatives5and6.However,astrik-
ing diﬀerence was the formation of double bond isomers in
the Heck coupling reaction. Even though this phenomenon
is well known in the ﬁeld of palladium catalyzed cross-
coupling reactions, we were surprised observing a strong
inﬂuence of the nature of the catalysts on formation of either
isomer. Thorough investigation of a variety of catalysts and
reaction conditions allowed us to tune reaction towards one
of the two possible isomers by the choice of the catalysts (H.
Nguyen,B.A ppel,andS.M¨ uller,manuscriptinpreparation).
The speciﬁc amino-modiﬁed adenosine derivatives shown in
Figure 2 were obtained with Na2[PdCl4]( 8, 9,a n d12)o r
with the catalyst palladacycle (11)[ 21].
The phosphoramidite building blocks 7, 10, 13,a n d14
carrying the propargylamino linker (Figure 2) were prepared
by Pd-catalyzed Sonogashira cross-coupling. Due to the
milder conditions compared with Heck chemistry, successful
Sonogashira reaction could be carried out at fully protected
nucleosides. Protection is not essential; however, we found
introduction of sugar and base protecting groups prior to
the cross-coupling reaction advantageous, since the overall
yield in this case was higher. The synthesis starts with the
introduction of the DMT- and TBDMS protecting group
via standard procedures [22, 23]. Then, the propargylamino
linker L3 was coupled to the nucleobase by SonogashiraJournal of Nucleic Acids 9
Table 2: Sequences of spin labelled RNAs. The bold U marks the position of 4-thiouridine, and the underlined U the position of 2 -aminou-
ridine.
Name Sequence Spin label Yield (%)
VW1 GGG CUA AAA CAU ACC AGA UUUCGA UCU GGA GAG GUG AAG AAU ACG
ACC ACC UAG CUC TPM-MTS 25
TMP-IAA 23
VW2 GGG CUA AAA CAU ACC AGA UUUCGA UCU GGA GAG GUG AAG AAU ACG
ACC ACC UAG CUC TPM-MTS 10
TMP-IAA 63
VW3 GGG CUA AAA CAUACC AGA UUUCGA UCU GGA GAG GUG AAG AAU ACG
ACC ACC UAG CUC TPM-MTS 20
TMP-IAA 80
VW4 GGG CUA AAA CAU ACC AGA UUUCGA UCU GGA GAG GUG AAG AAU ACG
ACC ACC UAG CUC TPM-MTS 77
VW5 GGG CUA AAA CAU ACC AGA UUUCGA UCU GGA GAG GUG AAG AAU ACG
ACC ACC UAG CUC TPM-MTS 25
VW6 GGG CUA AAA CAU ACC AGA UUUCGA UCU GGA GAG GUG AAG AAU ACG
ACC ACC UAG CUC TPM-MTS 100
VW7 GGG CUA AAA CAU ACC AGA UUUCGA UCU GGA GAG GUG AAG AAU ACG
ACC ACC UAG CUC TPM-MTS 61
VW8 GGG CUA AAA CAU ACC AGA UUUCGA UCU GGA GAG GUGA A GA A UA C G
ACC ACC UAG CUC TPM-MTS 13
VW9 GGG CUA AAA CAU ACC AGA UUU CGA UCU GGA GAG GUG AAG AAU
ACG ACC ACCUAG CUC TPM-MTS 45
VW10 GGG CUA AAA CAU ACC AGA UUUCGA UCU GGA GAG GUG AAG AAU ACG
ACC ACC UAG CUC TPM-MTS 89
VW11 GGG CUA AAA CAU ACC AGA UUUCGA UCU GGA GAG GUG AAG AAU ACG
ACC ACC UAG CUC TPM-MTS 89
VW12 GGG CUA AAA CAU ACC AGA UUUCGA UCU GGA GAG GUG AAG AAU ACG
ACC ACC UAG CUC TPM-MTS 10
HPAS11 ACC AGA GAA ACA GCC UUA GGA UAU GCU GG TMC-NHS 81
TEMPO-NCO 83
HPAS12 CCA GCA GAA GGA CGU CGU AUA UUA CCU GGU TMC-NHS 80
TEMPO-NCO 77
H P A S 1 3 A C CA G AG A AA C AA C CU U G GC TMC-NHS 82
TEMPO-NCO 97
HPAS14 GGC AAG GUC GUA UAU UAC CUG GU TMC-NHS 85
TEMPO-NCO 75
HPAS15 ACC AGA GAA ACA GAC UUG GC TMC-NHS 72
TEMPO-NCO 100
HPAS16 GCC AAG UCG UAU AUU ACC UGG U TMC-NHS 80
TEMPO-NCO 82
reaction, and ﬁnally, the phosphoramidite was prepared
as described above for the C5-propargylamino uridine
derivative.
Adenosine derivatives with the propargyl amino linker at
C8andC2werepreparedfollowingthesameroute.However,
as an additional step, the exocyclic amino group of the base
was protected prior to introduction of the other protecting
groups and of the linker unit.
The propargylamino linker was also attached to C8 of
guanosine starting from 8-bromoguanosine. The exocyclic
amino group was protected as an amide using isobutyric
anhydride. The DMT and the TBDMS group were intro-
duced according to standard methods [22, 23]a sd e s c r i b e d
above, and ﬁnally, the phosphoramidite was prepared with
4eq. of ethyl diisopropyl amine and 1.5eq. of 2-cyanoethyl-
N,N-diisopropylchlorophosphoramidite (Figure 4).10 Journal of Nucleic Acids
Table 3: Sequences of two-stranded or three-stranded amino modiﬁed aptazymes. APU: 5-(3-Aminoprop-1-enyl)uridine. AMU: 2 -amino-
uridine.
Name Length Sequence Mod. X
HPAT2-L12 72nts AAA GAG AGA AGU GAA CCA GAG AAA CAG CCU UAG GAU AXGC U UC G G
CAG AAG GAC GUC GUA UAU UAC CUG GUA APU
HPAT2-L14 72nts AAA GAG AGA AGU GAA CCA GAG AAA CAG CCU UAG GAX AUG CUU CGG
CAG AAG GAC GUC GUA UAU UAC CUG GUA APU
HPAT2-U12 72nts AAA GAG AGA AGU GAA CCA GAG AAA CAG CCU UAG GAU AXGC U UC G G
CAG AAG GAC GUC GUA UAU UAC CUG GUA AMU
HPAT2-U14 72nts AAA GAG AGA AGU GAA CCA GAG AAA CAG CCU UAG GAX AUG CUU CGG
CAG AAG GAC GUC GUA UAU UAC CUG GUA AMU
HPAT1-AAM 43nts AAA GAG AGA AGU GAA CCA GAG AAA CAG CCU UAG GAX AUG CUG G AMU
HPAT1-AHI 43nts AAA GAG AGA AGU GAA CCA GAG AAA CAG CCU UAG GAX AUG CUG G APU
HPAT1-BAM 43nts AAA GAG AGA AGU GAA CCA GAG AAA CAG CCU UAG GAU AXGC U GG A M U
HPAT1-BHI 43nts AAA GAG AGA AGU GAA CCA GAG AAA CAG CCU UAG GAU AXGC U GG A P U
HPAT2 31nts CCA GCA GAA GGA CGU CGU AUA UUA CCU GGU A —
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Several of the prepared phosphoramidite building blocks
were successfully incorporated into oligonucleotides using
standard solid phase chemistry (Table 1)[ 17]. The mod-
iﬁed phosphoramidites were thoroughly dried by repeti-
tive coevaporating with dichloromethane. After solving the
amidite in dry acetonitrile to a concentration of 0.1 to
0.15M, molecular sieves were added and the solution was
kept at room temperature for one hour prior to use. Amino-
modiﬁed phosphoramidites were coupled for 5 min, as were
the standard building blocks. The coupling yield was in
the 99% range, comparable with those of the unmodiﬁed
phosphoramidites. After synthesis, oligonucleotides were
deprotected under standard conditions [17], leading also to
removal of the TFA group protecting the aliphatic amine of
thelinker.Puriﬁcationwascarriedoutbygelelectrophoresis,
followed by MALDI-TOF MS analysis. Table 4 shows some
examplemassesofMALDI-TOF-MSdeterminationforsome
synthesized RNA oligonucleotides.
3.3. Postsynthetic Labeling. The amino-modiﬁed RNAs were
subsequently used for attachment of various dyes. Due to
selective reaction of activated carboxylic acids with aliphatic
amines, the fully deprotected RNA was used without the
danger of signiﬁcant side reactions at the sugar hydroxyl
groups or aromatic amino groups of the bases. In majority,
activate esters of Cy5, ATTO647N and Alexa488 were used
for postsynthetic labeling (Figure 5).
For Cy5 and ATTO647N, N-hydroxy-succinimidyl
(NHS) esters were used. For Alexa488, the NHS-ester is only
available as anisomeric mixture of 5- and 6-esters (Figure 6).
After reaction with the dye, RNAs labeled with either isomer
can be separated by gelelectrophoresis. However, we found
it being more eﬃcient using the tetraﬂuorophenyl (TFP)
ester of Alexa488, which is available as the pure 5-isomer
(Figure 6).
For each coupling reaction, an amount of 5 to 10 nmol
RNA was dissolved in borax buﬀer at pH 8.7 for labeling
with Cy5 and ATTO647N and pH 9.4 for reaction with
Alexa488. The dyes were added dissolved in DMF, and the
reaction was carried out at room temperature overnight in
the dark. Afterwards, the excess of dye was removed by
gel ﬁltration. Puriﬁcation of dye-labeled RNAs was carried
out by PAGE (Cy5- and Alexa488-labeled strands) or by
RP-HPLC (ATTO647N-labeled oligonucleotides). Successful
labeling was conﬁrmed by MALDI-TOF MS analysis. The
data shown in Table 5 a r er e p r e s e n t a t i v ee x a m p l e so fM S
analyzed dye labeled oligonucleotides.
Figure 7 shows the MALDI-TOF-MS spectra of the
oligonucleotide 2-L3-A prior to and after labeling with
ATTO647N, as an example for the superior quality of the
labeled oligonucleotides.
3.4. Hybridization of Single-Stranded RNAs for Structural
Studies. To demonstrate that the amino linkers as well as the
ﬂuorescent labels do not intervene in the hybridization of
single-stranded oligonucleotides, the hybrid of Alexa Fluor
488-labeled D1L3 and the complementary Cy5-labeled A1L3
was prepared (Figure 8). The oligonucleotides and their
hybrid were visualized by illumination with UV-light at 254
and 365 nm. As can be seen from the gel, the two dye-labeled
single-stranded oligonucleotides were fully hybridized.
In a parallel experiment, Alexa488-labeled D1L3 and
Cy5-labeledA1L3weredissolvedinKH2PO4-K2HPO4 buﬀer
containing MgCl2 and KCl, according to the required buﬀer
conditions in the FRET experiments to be conducted. The
mixture was mixed, incubated at 78◦Cf o r3m i n u t e s ,
and slowly cooled down to room temperature. Reaction
analysis by native polyacrylamide gel electrophoresis (data
not shown) conﬁrmed quantitative hybridization. Several of
the synthesized RNAs upon hybridization to their comple-
mentary strands were used in ﬂuorescence measurements, in
particular in single molecule detection (SMD) and time cor-
related single photon counting (TCSPC) bulk experiments
[14].
3.5. Synthesis of an Activated FMN Derivative for Postsynthetic
Labeling of Amino-Functionalized RNA. In previous work,
we have engineered an FMN responsive hairpin aptazyme
that can be switched on and oﬀ in a reversible mode [10].
As we have shown, FMN can be removed from its binding
pocket by reduction of the isoalloxazine ring, which is
associated with a change in geometry and subsequently with
loss of binding. In the original system, FMN was externally
added, requiring a 400-fold excess to saturate its binding
site in the aptazyme and to obtain a functional response.
Current work is focused on engineering a hairpin aptazyme
with FMN being covalently attached via a suitable linker.
This small molecular device is supposed to be advantageous
in terms of entropic costs for FMN binding to the aptamer
and iterative cycles of reversible switching. For this purpose,
a suitable FMN derivative for postsynthetic labeling of
amino-modiﬁed RNA was synthesized. Recent experiments
with diﬀerent FMN derivatives have shown that only the
isoalloxazine ring system is required for interaction with the
aptazyme, while the ribose unit as well as the phosphate do
n o ts e e mt op l a yam a j o rr o l e( T .M a r s c h a l la n dS .M ¨ uller,
unpublished observation). Thus, we decided to attach a
carboxyl group containing linker to the ribose chain of
riboﬂavin which subsequently could be postsynthetically
attached to amino-functionalized RNA as described in
Figures 5, 9,a n d10.
Starting from riboﬂavin, ﬁrst a fully protected riboﬂavin
derivative was synthesized. Protection of the 5 -OH group
was achieved by chemoselective tritylation of the primary
hydroxyl group with DMT-Cl in pyridine. The remaining
secondary hydroxyl groups were reacted with acetic anhy-
dride to give the fully protected derivative 22 in good yields
(83–90%). The selective deprotection of the 5 -OH group
under acidic conditions (2% DCA in DCM) led to the
formation of a side product with the same molecular mass
as the main product. This suggested the migration of one of
the acetyl groups under DMTdeprotection conditions. It has
been shown before that under acidic conditions, the acetyl
g r o u po ft h eC 4  -OH group can move to the neighbouring
C5 -OH group [24]. Separation of the two isomers by col-
umn chromatography on silica gel was not successful. There-
fore, we looked for alternative procedures. Alternatively to
acids, also ZnBr2 has been suggested as superior reagent12 Journal of Nucleic Acids
Table 4: Masses of the synthetic RNAs determined by MALDI-TOF-MS (linear negative-ion mode, found M = [M−H]−).
Sequence Cal. mass Found mass ΔmE r r o r ( % )
L2-TEST 2677.73 2675.99 0.77 0.027
2-L3-A 2585.63 2583.99 0.64 0.024
8-L1-A 2526.53 2525.96 0.43 0.017
A1L1 8041.95 8040.41 0.53 0.010
A1L2 8155.03 8153.15 0.88. 0.011
A1L3 8039.93 8039.23 0.30 0.003
A2L1 8041.95 8044.29 3.36 0.040
A2L3 8039.93 8041.17 2.24 0.030
D1L1 8098.93 8098.62 0.69 0.010
D1L2 8212.03 8211.46 0.43 0.005
D1L3 8096.93 8099.73 3.80 0.040
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Figure 5: Postsynthetic labeling of amino-modiﬁed oligonucleotides: (i) Chemical synthesis of amino-modiﬁed RNA; (ii) Deprotection;
(iii) Postsynthetic labeling with ﬂuorescent dyes.
for removal of DMT groups [25, 26]. Indeed, using ZnBr2
in dry nitromethane led to the formation of the desired
product 23 within a few minutes, without acetyl migration.
However, during puriﬁcation of the detritylated riboﬂavin
derivative by column chromatography, again migration of
acetyl protecting groups was observed. Therefore, the solid
crude product was just washed several times with ice cold
diethyl ether, yielding compound 23 with satisfying purity.
For the synthesis of the carboxylic acid containing linker
component, tetraethylene glycol was reacted with tert-butyl
acrylate (Figure 10). The product of this Michael addition
wasconvertedtothecorrespondingphosphoramiditewith2-
cyanoethyl-N,N-diisopropropylchlorophosphoramidite by
standard procedures [27]. The coupling reaction between
the riboﬂavin derivative 23 and the linker phosphoramidite
26 was accomplished in acetonitrile with BMT activation
followed by oxidation with an aqueous solution of iodine
to give the ﬂavinmononucleotide derivative 27. The fully
protected FMN derivative was treated with triﬂuoroacetic
acid in dichloromethane to eliminate the acid labile tert-
butyl protecting group (28). After the puriﬁcation of the free
acidformoftheFMNderivativebyRP-HPLC,cleavageofthe
β-cyanoethyl and the acetyl groups was achieved by stirring
in 30% ammonia in methanol. Evaporation of the ammonia
solutionandsubsequenttreatmentwithDOWEX(H+-form)
yielded the desired product 29 that upon activation as NHS
ester was used for postsynthetic RNA functionalization.
The FMN sensitive hairpin aptazyme was chemically
synthesized as a three-stranded or two-stranded system
using the phosphoramidite approach. In order to facilitate
coupling of the FMN derivative with the oligonucleotides,
2 -aminouridine or 5-propargylaminouridine (Figure 11)
were introduced in predeﬁned positions of the RNA chain,
providing the aliphatic amine for selective attachment of
the FMN derivative (Table 3). Suitable positions for FMN
attachment have been deﬁned on the basis of the structure
model of the FMN aptamer [28] with the help of PyMOL.
In order to couple the FMN derivative to the amino-
modiﬁed RNA, an NHS-ester was generated in situ by
reacting the unprotected FMN derivative 29 with 1.2eq.
TSTU and 2eq. DIPEA for one hour at room temperature
in DMF (Figure 12). The formation of the activated ester
was monitored by MALDI mass spectrometry. After all of
the free carboxylic acid had been converted to its NHS-form,
the FMN derivative was coupled to the amino group bearing
oligonucleotide. Successful coupling was conﬁrmed by poly-
acrylamide gel electrophoresis (Figure 12). The functional
characterization of the resulting FMN-RNA constructs in
ribozyme activity assays is currently in progress.Journal of Nucleic Acids 13
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Table 5: Masses of dye-labeled oligonucleotides determined by MALDI-TOF-MS (linear negative-ion mode, found M = [M+H]−).
Labeled sequence Cal. mass Found mass ΔmE r r o r ( % )
2-L3-A-ATTO 647N 3213.63 3212.44 0.19 0.006
A1L2-ATTO 647N 8783.03 8782.28 0.25 0.003
A2L2-ATTO 647N 8783.03 8776.95 5.08 0.057
A2L2-Cy5 8793.25 8791.53 0.72 0.008
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Figure 7: MALDI-TOF mass spectra of the amino-modiﬁed oligonucleotide 2-L3-A (a) and its corresponding conjugate with ATTO647N
(b). For the sequence of 2-L3-A, compare Table 1.14 Journal of Nucleic Acids
H
y
b
r
i
d
H
y
b
r
i
d
C
y
5
-
l
a
b
e
l
e
d
 
A
1
L
3
C
y
5
-
l
a
b
e
l
e
d
 
A
1
L
3
A
l
e
x
a
 
4
8
8
-
l
a
b
e
l
e
d
 
D
1
L
3
A
l
e
x
a
 
4
8
8
-
l
a
b
e
l
e
d
 
D
1
L
3
Cy5-labeled A1L3
Alexa 488-labeled D1L3
Donor
Acceptor
--
- - 5 
3 
254nm 365nm
5 
3  A
A
A A A
A AC C
C C C C C C C C C C
C C C C CC G
G G G G G G G G
G G G G G G G G GU
U U U
U U U
Figure 8: Hybridization of Alexa488-labeled D1L3 and Cy5-labeled A1L3: 3μM Alexa488-labeled D1L3: 3μM Cy5-labeled A1L3, 10mM
MgCl2,5 0m MT r i sb u ﬀe r ,p H7 . 4 ,t o t a lv o l u m e1 0 0μL, 78◦C 3min, slowly cooling to rt. The hybrid was analyzed by 15% native PAA-gel:
(left) illuminated at 254nm, (right) illuminated at 365nm.
N
N
N
NH
O
O
OH
OH
OH
HO
N
N
N
NH
O
O
ODMT
OH
OH
HO
N
N
N
NH
O
O
ODMT
OAc
OAc
AcO
N
N
N
NH
O
O
OH
OAc
OAc
AcO
(iii) (ii) (i)
22 20 21 23
Figure 9: Synthesis of protected riboﬂavine derivatives: (i) DMT-Cl, DMAP, pyridine, rt, overnight (53%); (ii) acetic anhydride, pyridine,
0◦C → rt, overnight (90%); (iii) ZnBr2 in nitromethane, 2min (83%).
HO
O
OH 3 HO
O O
3
O
O O O
O
P
O
N
NC
3
N
N
N
NH
O
O
O
OR2
OR2
R2O
R3O O O
O OR1
O
P
3
O
24 26
23
(i) (ii)
(iii)
25
Compound R1 R2 R3
27
28
29
Ac CE
HA c C E
HH H
tBu
OtBu OtBu
27–29
Figure 10: Synthesis of the fully protected linker unit: (i) Na, tert-butyl acrylate, THF, rt, 1d (34%); (ii) 2-Cyanoethyl-N,N-diisopropropyl-
chlorophosphoramidite, DIPEA, DCM, rt, 1.5h (quant.); (iii) (a) BMT, MeCN, rt, 1h; (b) 0.2 M I2 in THF/pyridine/H2O (2:1:1) (32%).Journal of Nucleic Acids 15
5-(3-Aminopro-1-enyl) uridine
(APU)
NH
O
O N
O
NH2 O
O
NH
O
O N
O
OH O
O
H2N
5 
5 
3  3 
2 -Aminouridine
(AMU)
(a)
H2N
H2N
H2N
H2N
(b)
Figure 11: (a) Structure of the two nucleotide analogs used for the incorporation of an aliphatic amino group into the aptazyme RNA.
(b) Two-stranded (left) and three-stranded (right) aptazyme. The modiﬁcations AMU and APU are located at position U12 (red) and U14
(green), respectively.
3.6. Synthesis of Speciﬁcally Spin-Labeled RNAs. Within a
collaborative project on structural analysis of the tetracycline
dependent riboswitch [9] and of the FMN responsive
aptazymedescribedabove[10]byelectronparamagneticres-
onance (EPR) spectroscopy, we have synthetically prepared
RNAs carrying a suitable spin label at a predeﬁned site.
Thebasicstrategyofsite-directedspin-labelingoriginallyhas
been developed with proteins and involves modiﬁcation of
theSHgroupofanappropriatecysteinewithaselectivepara-
magnetic nitroxide reagent. Applying the same technique
to RNA, labeling initially was achieved by incorporating a
guanosine monophosphorothioate at the 5 -end followed by
spin-labeling at the sulfur [29]. The strategy was extended
towards site-speciﬁc introduction of a phosphorothioate
group at RNA backbone locations or of modiﬁed bases such
as 4-thiouridine and subsequent attachment of a suitably
activated nitroxide spin label [30–32]. More recent work
employs aliphatic amino groups at the 2 -position of a
speciﬁc sugar residue or attached at the heterocyclic base
[33–35].
We have made use of two diﬀerent strategies, incor-
porating either 4-thiouridine or 2 -aminouridine into RNA
followed by postsynthetic reaction with the nitroxide spin
label. For reaction with 4-thiouridine containing RNAs,
(1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl)methanethi-
osulfonate (TPM-MTS) and N-(1-oxyl- 2,2,5,5-tetramethyl-
3-pyrrolidinyl) iodoacetamide (TMP-IAA) was used, for
reaction with 2 -aminouridine containing RNA, (1oxyl-
2,2,5,5-tetramethylpyrrolin-3-carboxylate)-N-hydroxy-
succinimidyl ester (TMC-NHS) or 4-isocyanato-2,6-tetram-
ethylpiperidylN-oxid (TEMPO-NCO) (Figure 13). As men-
tioned already above, the 12 modiﬁed RNAs VW1 to VW12
shown in Table 2 were synthesized within a structural study
of a tetracycline responsive RNA aptamer [9]. HPAS11 and
HPAS16 were synthesized and spin labeled for an EPR study
of an artiﬁcial ﬂavin mononucleotide responsive riboswitch
[10].
For RNAs labeled via 4-thiouridine, reaction with the
TPM-MTS spin label was favored, because initial EPR mea-
surements showed that the TMP-IAA label has suboptimal
properties, presumably because it is too mobile due to the
rather ﬂexible CH2-CO-NH-CH2-spacer (Figure 13,l o w e r
part). Therefore, the majority of 4-thiouridine containing
RNAs was reacted with TPM-MTS for introduction of
the less mobile nitroxide spin label. The yields shown in
Table 2 were reproduced in up to ﬁve labeling reactions
for each individual RNA. Thus, the variation of labeling
eﬃciency observed for individual RNAs suggests that the
structure of the RNA aptamer signiﬁcantly inﬂuences the
labeling reaction,making spin labeling ofindividual uridines
dependent on the speciﬁc location in the aptamer sequence.
A second point that may account for the observed low
labeling eﬃciency is the rather unstable disulﬁde bond
attaching the spin label at the uracil residue. Therefore, as an
alternative, we have also studied conditions for spin labeling
via the RNA sugar-phosphate backbone (Figure 14). To this
end, RNAs containing 2 -aminouridine at a speciﬁc position
(HPAS11 to HPAS16) were synthesized and labeled using
either TEMPO-NCO or TMC-NHS. It has been described
in the literature that the steric hindrance of the 2 -NH2-
group hampers reaction with NHS esters [36]. Therefore,
we have extended the reaction time from 15 minutes to
4 hours and used a 500-fold excess of the NHS-reagent
to overcome the problem of low reaction yields. On the
contrary to NHS esters, isocyanates were shown to virtually
quantitatively react with 2 -amino sugars [33]. However,
being less selective, side reactions at the nucleobases were
observed when a high excess of the isocyanate reagent was
used [37]. The authors have optimized reaction conditions
such that a 2 -amino group was selectively modiﬁed without
concurrent side reaction. In that, they observed an increase
of the yield of the modiﬁed oligonucleotide upon lowering
thetemperature,whichpresumablyistheresultofrepression
of competing isocyanate hydrolysis [37]. In parallel rows of
labeling reactions under varying conditions, we have also
lookedatreactionconditionstodeliverthespin-labeledRNA
with high yield and high quality. Best results were obtained
with an only 15-fold excess of the isocyanate reagent over
RNA, and a reaction temperature of −8◦C. Under these
conditions, about 80% labeling eﬃciency were reproducibly16 Journal of Nucleic Acids
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obtained for both labeling reagents with all RNA samples
(Table 2). In order to avoid side reactions, we have added the
spin label reagent only once in 15-fold excess even though
it was originally described that repeated additions of the
reagent give nearly quantitative results [33]. EPR spectra of
RNAs showed that the spin labels conjugated via the 2 -
aminogroupareratherimmobile(H.-J.Steinhoﬀ,University
Osnabr¨ uck, oral information), making labeling via this
position most favorable. It was somewhat surprising that
mobility of TEMPO seemed to be even more limited than
that of the TPC- label, because the 6-membered piperidyl
ring is conformationally more ﬂexible than the 5-membered
pyrroline ring. Obviously, the nature of the spacer unit (urea
versus amide bond) also has a strong inﬂuence. Overall, in
the speciﬁc context of RNA sequences shown in Table 2,
2 -amino sugar labeling is advantageous over 4-thiouridine
labeling in terms of eﬃciency and immobility.
4. Conclusion
As demonstrated above, the chemical synthesis of RNA
oﬀers the possibility of site-speciﬁc introduction of modiﬁed
nucleosides. This is an important advantage over enzymatic
procedures, making RNA synthesis an essential tool for a
largenumberofstudiesindiﬀerentﬁelds.Wehavesucceeded
in the synthesis of a number of monomer building blocks
that upon incorporation in RNA allow for postsynthetic
attachment of spectroscopic reporter groups or other desired
functionalities.Theamino-modiﬁedmonomerspresentedin
this paper are a valuable addition to the RNA chemist’s tool
box. Due to the diﬀerent length and ﬂexibility of the linkers
that carry the aliphatic amino groups for postsynthetic
functionalization,molecularentitiesthatbecomeattachedto
the RNA have diﬀering degrees of motional freedom. This is
of particular interest for ﬂuorescence spectroscopic studies,
because systematic errors may result from ﬂuorescence dyes
that are sterically hindered, or on the contrary are too
mobile,limitingtheaccuracyofthemeasurement.Therefore,
using our amino linker building blocks of the U series
(Figure 2), an extensive analysis of the inﬂuence of the linker
lengths and rigidity on the accuracy of FRET measurements
was carried out [14]. The results will pave the way for more
sophisticated studies of RNA structure dynamics. Likewise,
EPR spectroscopic analysis of RNA will proﬁt from the new
building blocks, since spin labels attached to the RNA of
interest,aresubjectedtothesameconditionsandrestrictions
as the ﬂuorescent dyes in ﬂuorescence spectroscopy.
Lastly, we have synthesized an FMN-RNA conjugate
to be used for functional studies of an FMN responsive
aptazyme. This example shows that there is much room
for RNA engineering and construction of sophisticated
RNA devices. Organic chemistry oﬀers a large number of
possibilities to prepare suitably activated modiﬁers that can
be postsynthetically attached to amino-modiﬁed RNA, or
to RNA carrying other functionalities such as for example
thiol groups, or alkynes and azides as used for labeling
by Click chemistry [38]. Thus, in combination with the
development of synthetic routes to appropriately activated
modiﬁers, RNAs can be conjugated with a large variety of
tags,makingthenucleicacidnotonlyvisibleinspectroscopicJournal of Nucleic Acids 17
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experiments, but also adding new functionality as demon-
strated with the RNA-FMN conjugate described herein.
Abbreviations
CE: Cyanoethyl
DCM: Dichloromethane
DIPEA: Diisopropylethylamine
DMA: Dimethylamine
DMAP: Dimethylaminopyridin
DMF: Dimethylformamide
DMT: Dimethoxytrityl
MeCN: Acetonitril
TBDMS: tert-butyldimethylsilyl
TEA: Triethylamine
BMT: 1-(Benzylmercapto)-1H-tetrazole
TEMPO-NCO: 4-isocyanato-2,6-tetramethylpiperidyl-
N-oxyl
TFA: Triﬂuoroacetic acid
TMC-NHS: (1-oxyl-2,2,5,5-tetramethylpyrrolin-3-
carboxylat)-N-hydroxysuccinimidyl
ester
TMP-IAA: N-(1-oxyl-2,2,5,5-tetramethyl-3-
pyrrolidinyl)
iodoacetamide
TPM-MTS: (1-oxyl-2,2,5,5-tetramethylpyrroline-3-
methyl)methanethiosulfonate.
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